Cockwell, P. & Fisher, L.-A. The global burden of chronic kidney disease. Lancet 395, 662–664 (2020).
Bikbov, B. et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 395, 709–733 (2020).
Couser, W. G., Remuzzi, G., Mendis, S. & Tonelli, M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 80, 1258–1270 (2011).
Jha, V. et al. Chronic kidney disease: Global dimension and perspectives. Lancet 382, 260–272 (2013).
Ekrikpo, U. E. et al. Chronic kidney disease in the global adult HIV-infected population: A systematic review and meta-analysis. PLoS One 13, e0195443 (2018).
Saran, R. et al. US Renal Data System 2015 Annual Data Report: Epidemiology of kidney disease in the United States. Am. J. Kidney Dis. 67, A7–A8 (2016).
Levey, A. S. & Coresh, J. Chronic kidney disease. Lancet 379, 165–180 (2012).
Ruggenenti, P., Cravedi, P. & Remuzzi, G. Mechanisms and Treatment of CKD. J. Am. Soc. Nephrol. 23, 1917–1928 (2012).
Levey, A. S. et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 67, 2089–2100 (2005).
Gorski, M. et al. Meta-analysis uncovers genome-wide significant variants for rapid kidney function decline. Kidney Int. 99, 926–939 (2021).
Teumer, A. et al. Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria. Nat. Commun. 10, 4130 (2019).
Morris, A. P. et al. Trans-ethnic kidney function association study reveals putative causal genes and effects on kidney-specific disease aetiologies. Nat. Commun. 10, 29 (2019).
Sollis, E. et al. The NHGRI-EBI GWAS Catalog: Knowledgebase and deposition resource. Nucleic Acids Res. 51, D977–D985 (2023).
Lee, D. D. & Seung, H. S. Learning the parts of objects by non-negative matrix factorization. Nature 401, 788–791 (1999).
Paatero, P. & Tapper, U. Positive matrix factorization: A non-negative factor model with optimal utilization of error estimates of data values. Environmetrics 5, 111–126 (1994).
Févotte, C. & Idier, J. Algorithms for nonnegative matrix factorization with the β-divergence. Neural Comput. 23, 2421–2456 (2011).
Udler, M. S. et al. Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysis. PLoS Med. 15, e1002654 (2018).
Kim, H. et al. High-throughput genetic clustering of type 2 diabetes loci reveals heterogeneous mechanistic pathways of metabolic disease. Diabetologia 66, 495–507 (2023).
DiCorpo, D. et al. Type 2 diabetes partitioned polygenic scores associate with disease outcomes in 454,193 individuals across 13 cohorts. Diabetes Care 45, 674–683 (2022).
Chun, S. et al. Non-parametric polygenic risk prediction via partitioned GWAS summary statistics. Am. J. Hum. Genet. 107, 46–59 (2020).
Tait Wojno, E. D., Hunter, C. A. & Stumhofer, J. S. The immunobiology of the interleukin-12 family: Room for discovery. Immunity 50, 851–870 (2019).
Bhatia, M. et al. Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells. J. Exp. Med. 189, 1139–1148 (1999).
Liu, J.-R. et al. Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation. Cell. Mol. Life Sci. 78, 909–922 (2021).
Choi, S. W., Mak, T.S.-H. & O’Reilly, P. F. Tutorial: A guide to performing polygenic risk score analyses. Nat. Protoc. 15, 2759–2772 (2020).
Gagnebin, Y. et al. Exploring blood alterations in chronic kidney disease and haemodialysis using metabolomics. Sci. Rep. 10, 19502 (2020).
Vanholder, R. et al. Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int. 63, 1934–1943 (2003).
Stenvinkel, P. & Lindholm, B. C-reactive protein in end-stage renal disease: Are there reasons to measure it?. Blood Purif. 23, 72–78 (2005).
Kalantar-Zadeh, K., Stenvinkel, P., Pillon, L. & Kopple, J. D. Inflammation and nutrition in renal insufficiency. Adv. Ren. Replace. Ther. 10, 155–169 (2003).
Hansson, G. K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685–1695 (2005).
Stenvinkel, P. et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 55, 1899–1911 (1999).
Li, Z. et al. C-reactive protein promotes acute renal inflammation and fibrosis in unilateral ureteral obstructive nephropathy in mice. Lab. Investig. 91, 837–851 (2011).
Stuveling, E. M. et al. C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int. 63, 654–661 (2003).
Menon, V. et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int. 68, 766–772 (2005).
Muntner, P. et al. The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann. Intern. Med. 140, 9 (2004).
Theofilis, P., Vordoni, A., Koukoulaki, M., Vlachopanos, G. & Kalaitzidis, R. G. Dyslipidemia in chronic kidney disease: Contemporary concepts and future therapeutic perspectives. Am. J. Nephrol. 52, 693–701 (2021).
Farooqui, A. A., Horrocks, L. A. & Farooqui, T. Glycerophospholipids in brain: Their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chem. Phys. Lipids 106, 1–29 (2000).
Frisardi, V., Panza, F., Seripa, D., Farooqui, T. & Farooqui, A. A. Glycerophospholipids and glycerophospholipid-derived lipid mediators: A complex meshwork in Alzheimer’s disease pathology. Prog. Lipid Res. 50, 313–330 (2011).
Chen, H. et al. Combined clinical phenotype and lipidomic analysis reveals the impact of chronic kidney disease on lipid metabolism. J. Proteome Res. 16, 1566–1578 (2017).
Sirugo, G., Williams, S. M. & Tishkoff, S. A. The missing diversity in human genetic studies. Cell 177, 26–31 (2019).
Lin, B. M. et al. Genetics of chronic kidney disease stages across ancestries: The PAGE study. Front. Genet. 10, 494 (2019).
Alexandrov, L. B., Nik-Zainal, S., Wedge, D. C., Campbell, P. J. & Stratton, M. R. Deciphering signatures of mutational processes operative in human cancer. Cell Rep. 3, 246–259 (2013).
Stanzick, K. J. et al. Discovery and prioritization of variants and genes for kidney function in >1.2 million individuals. Nat. Commun. 12, 4350 (2021).
Lin, B. M. et al. Whole genome sequence analyses of eGFR in 23,732 people representing multiple ancestries in the NHLBI trans-omics for precision medicine (TOPMed) consortium. EBioMedicine 63, 103157 (2021).
Machiela, M. J. & Chanock, S. J. LDlink: A web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants: Fig. 1. Bioinformatics 31, 3555–3557 (2015).
Myers, T. A., Chanock, S. J. & Machiela, M. J. LDlinkR: An R package for rapidly calculating linkage disequilibrium statistics in diverse populations. Front. Genet. 11, 157 (2020).
Quintero, A. et al. ShinyButchR: Interactive NMF-based decomposition workflow of genome-scale datasets. Biol. Methods Protoc. 5, bpaa022 (2020).
Wu, T. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).
Kanehisa, M. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27–30 (2000).
Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587–D592 (2023).
Milacic, M. et al. The reactome pathway knowledgebase 2024. Nucleic Acids Res. 52, D672–D678 (2024).
Liberzon, A. et al. The molecular signatures database hallmark gene set collection. Cell Syst. 1, 417–425 (2015).
Krämer, A., Green, J., Pollard, J. & Tugendreich, S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics 30, 523–530 (2014).
Liao, Y., Wang, J., Jaehnig, E. J., Shi, Z. & Zhang, B. WebGestalt 2019: Gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 47, W199–W205 (2019).
Purcell, S. et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).
BioMe BioBank Program | Icahn School of Medicine. Icahn School of Medicine at Mount Sinai. https://icahn.mssm.edu/research/ipm/programs/biome-biobank
Belbin, G. M. et al. Toward a fine-scale population health monitoring system. Cell 184, 2068-2083.e11 (2021).
Manichaikul, A. et al. Robust relationship inference in genome-wide association studies. Bioinformatics 26, 2867–2873 (2010).
Price, A. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904–909 (2006).
The 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 526, 68–74 (2015).
Quality Control (QC) | Pan UKBB. https://pan-dev.ukbb.broadinstitute.org/docs/qc
R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2013).
Denny, J. C. et al. Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat. Biotechnol. 31, 1102–1111 (2013).
Nadkarni, G. N. et al. Development and validation of an electronic phenotyping algorithm for chronic kidney disease. AMIA Annu. Symp. Proc. AMIA Symp. 2014, 907–916 (2014).
Ben-Shachar, M., Lüdecke, D. & Makowski, D. effectsize: Estimation of effect size indices and standardized parameters. J. Open Source Softw. 5, 2815 (2020).
- The Renal Warrior Project. Join Now
- Source: https://www.nature.com/articles/s41598-024-59747-4